应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06622 兆科眼科-B
休市中 10-23 16:08:08
1.900
-0.040
-2.06%
最高
1.970
最低
1.890
成交量
20.50万
今开
1.970
昨收
1.940
日振幅
4.12%
总市值
10.43亿
流通市值
10.43亿
总股本
5.49亿
成交额
39.27万
换手率
0.04%
流通股本
5.49亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
兆科眼科-B回购12,000股股份,耗资约2.30万港元
公告速递 · 10-23 16:47
兆科眼科-B回购12,000股股份,耗资约2.30万港元
兆科眼科-B:10月22日回购5.35万股,耗资约10.30万港元
公告速递 · 10-22 17:26
兆科眼科-B:10月22日回购5.35万股,耗资约10.30万港元
兆科眼科-B(06622.HK)10月22日斥资10.3万港元回购5.35万股
智通财经 · 10-22 17:22
兆科眼科-B(06622.HK)10月22日斥资10.3万港元回购5.35万股
兆科眼科-B10月21日回购1,000股股份,涉资2,065港元
公告速递 · 10-21 16:51
兆科眼科-B10月21日回购1,000股股份,涉资2,065港元
兆科眼科-B:10月21日斥资2065港元回购1000股
南方财经网 · 10-21 16:51
兆科眼科-B:10月21日斥资2065港元回购1000股
兆科眼科-B 10月20日回购5500股,涉资约1.13万港元
公告速递 · 10-20
兆科眼科-B 10月20日回购5500股,涉资约1.13万港元
兆科眼科-B(06622)10月20日斥资1.13万港元回购5500股
智通财经 · 10-20
兆科眼科-B(06622)10月20日斥资1.13万港元回购5500股
兆科眼科-B(06622)10月16日回购4,500股,涉资约9,172.35港元
公告速递 · 10-20
兆科眼科-B(06622)10月16日回购4,500股,涉资约9,172.35港元
兆科眼科-B回购7,500股股份,耗资约1.56万港元
公告速递 · 10-20
兆科眼科-B回购7,500股股份,耗资约1.56万港元
兆科眼科-B:10月16日回购4,500股,耗资约9,172.35港元
公告速递 · 10-16
兆科眼科-B:10月16日回购4,500股,耗资约9,172.35港元
兆科眼科-B(06622.HK)10月16日耗资9172.35港元回购4500股
智通财经 · 10-16
兆科眼科-B(06622.HK)10月16日耗资9172.35港元回购4500股
兆科眼科-B:10月14日回购7,500股股份,总额约1.56万港元
公告速递 · 10-15
兆科眼科-B:10月14日回购7,500股股份,总额约1.56万港元
兆科眼科-B(06622)10月14日斥资3202.5港元回购1500股
智通财经 · 10-15
兆科眼科-B(06622)10月14日斥资3202.5港元回购1500股
兆科眼科-B更新9月股份变动月报表,股本结构保持稳定
公告速递 · 10-02
兆科眼科-B更新9月股份变动月报表,股本结构保持稳定
兆科眼科-B 2026年中期营收1,882.80万元,经调整净亏损1.16亿元
公告速递 · 09-30
兆科眼科-B 2026年中期营收1,882.80万元,经调整净亏损1.16亿元
董事总经理李烨妮增持李氏大药厂(00950.HK)20.6万股 每股作价1.15港元
智通财经 · 09-24
董事总经理李烨妮增持李氏大药厂(00950.HK)20.6万股 每股作价1.15港元
创新药概念走高,云顶新耀、药明巨诺-B涨逾5%,金斯瑞生物科技涨逾4%
老虎资讯综合 · 09-23
创新药概念走高,云顶新耀、药明巨诺-B涨逾5%,金斯瑞生物科技涨逾4%
兆科眼科-B:YUVEZZI™中国II期临床达主要终点,拟推进III期试验
公告速递 · 09-04
兆科眼科-B:YUVEZZI™中国II期临床达主要终点,拟推进III期试验
兆科眼科-B(06622.HK):卡巴胆硷酒石酸溴莫尼定滴眼液(YUVEZZI™)于中国老花眼患者的第II期研究中达到主要研究终点
智通财经 · 09-04
兆科眼科-B(06622.HK):卡巴胆硷酒石酸溴莫尼定滴眼液(YUVEZZI™)于中国老花眼患者的第II期研究中达到主要研究终点
兆科眼科-B8月股份变动月报:已发行股份增至548,839,012股
公告速递 · 09-02
兆科眼科-B8月股份变动月报:已发行股份增至548,839,012股
加载更多
公司概况
公司名称:
兆科眼科-B
所属市场:
SEHK
上市日期:
--
主营业务:
兆科眼科有限公司是一家主要从事眼科药物及产品的开发、生产及营销的投资控股公司。该公司的主要产品包括用于治疗近视的NVK002(阿托品)、用于治疗干眼症的环孢素A眼凝胶以及用于治疗wAMD的TAB014(贝伐单抗)。该公司产品主要用于干眼症(DED)、近视、老花眼、湿性老年黄斑部病变(wAMD)和糖尿病黄斑水肿(DME)、青光眼及角膜上皮细胞功能障碍(CED)等影响眼前节及眼后节的眼科疾病的治疗。该公司在中国国内及海外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"06622","market":"HK","secType":"STK","nameCN":"兆科眼科-B","latestPrice":1.9,"timestamp":1792742888227,"preClose":1.94,"halted":0,"volume":205000,"delay":0,"changeRate":-0.020618556701030948,"floatShares":549000000,"shares":549000000,"eps":-0.4493140677421126,"marketStatus":"休市中","change":-0.04,"latestTime":"10-23 16:08:08","open":1.97,"high":1.97,"low":1.89,"amount":392657,"amplitude":0.041237,"askPrice":1.97,"askSize":12000,"bidPrice":1.9,"bidSize":30000,"shortable":0,"etf":0,"ttmEps":-0.46135077788147094,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792978200000},"marketStatusCode":7,"adr":0,"listingDate":1619625600000,"exchange":"SEHK","adjPreClose":1.94,"openAndCloseTimeList":[[1792719000000,1792728000000],[1792731600000,1792742400000]],"volumeRatio":0.88288317745508,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06622","defaultTab":"news","newsList":[{"id":"1128464802","title":"兆科眼科-B回购12,000股股份,耗资约2.30万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1128464802","media":"公告速递","labels":[],"top":1,"itemType":null,"share":"https://www.laohunote.com/m/news/1128464802?lang=zh_cn&edition=full","pubTime":"2026-10-23 16:47","pubTimestamp":1792745261,"startTime":"0","endTime":"0","summary":"兆科眼科-B于2026年10月23日发布翌日披露报表,宣布在香港联交所场内回购12,000股普通股。该股份数约占公司已发行股本的0.00219%,每股购回价介乎1.89港元至1.97港元,支付总金额为22,980港元,折合约2.30万港元。公司确认回购后其已发行股本总数仍为548,839,012股,库藏股数为0股。公告还披露,新股发行或库藏股再出售将自回购之日起30日内受到限制。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"兆科眼科-B回购12,000股股份,耗资约2.30万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06622"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132695085","title":"兆科眼科-B:10月22日回购5.35万股,耗资约10.30万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1132695085","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132695085?lang=zh_cn&edition=full","pubTime":"2026-10-22 17:26","pubTimestamp":1792661199,"startTime":"0","endTime":"0","summary":"兆科眼科-B(06622)于2026年10月22日发布公告,披露在香港联交所场内回购股份。公告显示,公司当日共回购5.35万股普通股,占已发行股本约0.00975%,回购价格介乎每股1.885港元至2.00港元,合计耗资约10.30万港元。回购后,公司已发行股本数维持548,839,012股,暂无任何库藏股。\n公司于2026年5月15日通过购回授权,最多可回购54,874,901股。截至目前,已累计回购1,793,000股,占授权通过当日已发行股本约3.2674%。公司同时表示,本次股份回购已获董事会正式授权,完成过程中遵守了香港联交所上市规则及相关法律法规。\n本次公告由董事李小羿签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"兆科眼科-B:10月22日回购5.35万股,耗资约10.30万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06622"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677865955","title":"兆科眼科-B(06622.HK)10月22日斥资10.3万港元回购5.35万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2677865955","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677865955?lang=zh_cn&edition=full","pubTime":"2026-10-22 17:22","pubTimestamp":1792660970,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1587","06622","BK1191","BK1574","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146552591","title":"兆科眼科-B10月21日回购1,000股股份,涉资2,065港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1146552591","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146552591?lang=zh_cn&edition=full","pubTime":"2026-10-21 16:51","pubTimestamp":1792572710,"startTime":"0","endTime":"0","summary":"兆科眼科-B于2026年10月21日发布公告,披露公司已在香港联交所场内回购公司股份。根据公告,兆科眼科-B在当日回购1,000股普通股,占公司已发行股本的0.00018%。本次回购的最高购买价为每股2.065港元,最低购买价为每股2.005港元,总涉资2,065港元。公司所持有的购回授权于2026年5月15日通过,可回购股份总数为54,874,901股,截至目前已累计回购1,739,500股,占授权总数的3.17%。公司在公告中确认,已遵守香港联合交易所有限公司证券上市规则及其他相关法律法规的规定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"兆科眼科-B10月21日回购1,000股股份,涉资2,065港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06622"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677621620","title":"兆科眼科-B:10月21日斥资2065港元回购1000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2677621620","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677621620?lang=zh_cn&edition=full","pubTime":"2026-10-21 16:51","pubTimestamp":1792572660,"startTime":"0","endTime":"0","summary":"南财智讯10月21日电,兆科眼科-B(06622.HK)发布翌日披露报表,10月21日,公司回购1000股,每股最高回购价为2.07港元,每股最低回购价为2.01港元,付出的总代价为2065港元,回购股份拟注销。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610213902681546.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610213902681546.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06622","EWH","BK1574","BK1191","BK1583","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138410606","title":"兆科眼科-B 10月20日回购5500股,涉资约1.13万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1138410606","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1138410606?lang=zh_cn&edition=full","pubTime":"2026-10-20 17:45","pubTimestamp":1792489550,"startTime":"0","endTime":"0","summary":"兆科眼科-B于2026年10月20日发布翌日披露报表显示,公司当日于香港联交所场内回购股票5500股,每股购回价介乎港币2.0元至2.1元,合计耗资约1.13万港元。购回股份拟作注销处理但截至公告日尚未注销。公告称,本次回购前后,公司已发行股本均为548,839,012股,库藏股数量均为0。根据此前于2026年5月15日通过的购回授权,公司可回购股份总数为54,874,901股,截至目前已在本交易所或其他证交所购回1,733,000股,占购回授权获通过当日已发行股本的约3.1581%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"兆科眼科-B 10月20日回购5500股,涉资约1.13万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06622"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676661372","title":"兆科眼科-B(06622)10月20日斥资1.13万港元回购5500股","url":"https://stock-news.laohu8.com/highlight/detail?id=2676661372","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676661372?lang=zh_cn&edition=full","pubTime":"2026-10-20 17:41","pubTimestamp":1792489302,"startTime":"0","endTime":"0","summary":"智通财经APP讯,兆科眼科-B(06622)发布公告,于2026年10月20日,该公司斥资1.13万港元回购5500股股份,每股回购价2-2.1港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1509492.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1574","06622","BK1583","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120297502","title":"兆科眼科-B(06622)10月16日回购4,500股,涉资约9,172.35港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1120297502","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1120297502?lang=zh_cn&edition=full","pubTime":"2026-10-20 17:41","pubTimestamp":1792489273,"startTime":"0","endTime":"0","summary":"2026年10月16日,兆科眼科有限公司在香港联交所发布翌日披露报表。公告显示,公司于当日于联交所场内回购普通股4,500股,占交易日已发行股本约0.00082%,回购价格在每股2.025港元至2.1港元之间,总金额约9,172.35港元。回购股份尚未注销,回购后公司已发行股份总数仍为548,839,012股,且暂无库藏股。根据公告,兆科眼科-B于2026年5月15日通过购回授权,可购回最多54,874,901股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"兆科眼科-B(06622)10月16日回购4,500股,涉资约9,172.35港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06622"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174874837","title":"兆科眼科-B回购7,500股股份,耗资约1.56万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1174874837","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1174874837?lang=zh_cn&edition=full","pubTime":"2026-10-20 17:41","pubTimestamp":1792489263,"startTime":"0","endTime":"0","summary":"兆科眼科-B于2026年10月15日发布翌日披露报表,公告显示公司在香港联交所场内回购7,500股股份,占已发行股本约0.0014%。每股回购价格介乎港币2.05元至2.09元,合计动用约15,587.25港元。公司披露,本次回购基于股东于2026年5月15日通过的购回授权,该授权允许累计回购最多54,874,901股。截至本次回购,已回购股份总数达1,728,500股,占该购回授权当日已发行股本的约3.1499%。公司表示,本次交易遵守香港联合交易所有限公司的证券上市规则及相关法律规定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"兆科眼科-B回购7,500股股份,耗资约1.56万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06622"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109170219","title":"兆科眼科-B:10月16日回购4,500股,耗资约9,172.35港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1109170219","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1109170219?lang=zh_cn&edition=full","pubTime":"2026-10-16 17:52","pubTimestamp":1792144341,"startTime":"0","endTime":"0","summary":"兆科眼科-B(股票代码:06622)于2026年10月16日发布公告,披露于香港联交所回购4,500股普通股,回购价格介乎每股2.025港元至2.10港元,合计投入约9,172.35港元。公司强调已遵守相关上市规则及法律规定,并确认该等回购已获董事会正式授权批准。\n公告显示,回购授权于2026年5月15日获股东大会通过,授权最多回购54,874,901股。截至本次交易,公司自该授权下累计回购股份1,733,000股,占授权通过当日公司已发行股本总数的3.1581%。本次交易后,公司已发行股本总数维持为548,839,012股,尚无库存股份。\n上述公告由公司董事李小羿签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"兆科眼科-B:10月16日回购4,500股,耗资约9,172.35港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06622"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675598035","title":"兆科眼科-B(06622.HK)10月16日耗资9172.35港元回购4500股","url":"https://stock-news.laohu8.com/highlight/detail?id=2675598035","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675598035?lang=zh_cn&edition=full","pubTime":"2026-10-16 17:46","pubTimestamp":1792143986,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["06622","BK1583","BK1191","BK1587","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145879970","title":"兆科眼科-B:10月14日回购7,500股股份,总额约1.56万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1145879970","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1145879970?lang=zh_cn&edition=full","pubTime":"2026-10-15 18:06","pubTimestamp":1792058805,"startTime":"0","endTime":"0","summary":"兆科眼科有限公司于2026年10月15日发布翌日披露报表,披露其于2026年10月14日在香港联交所场内回购普通股7,500股,回购价格介乎每股2.05港元至2.09港元,合计耗资约15,587.25港元。根据公告,本次回购股份将作为库存股份后续拟予以注销,相关股份占购回授权通过时公司已发行股本的部分。公司已于2026年5月15日获得股东大会通过的回购授权,最多可回购54,874,901股。公告显示,至2026年10月15日止,公司已发行股本总数仍为548,839,012股,库存股份数量为0股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"兆科眼科-B:10月14日回购7,500股股份,总额约1.56万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06622"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675377159","title":"兆科眼科-B(06622)10月14日斥资3202.5港元回购1500股","url":"https://stock-news.laohu8.com/highlight/detail?id=2675377159","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675377159?lang=zh_cn&edition=full","pubTime":"2026-10-15 12:16","pubTimestamp":1792037818,"startTime":"0","endTime":"0","summary":"智通财经APP讯,兆科眼科-B(06622)发布公告,于2026年10月14日该公司斥资3202.5港元回购1500股,回购价格为每股2.135港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1507512.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1583","EWH","BK1587","06622","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139797475","title":"兆科眼科-B更新9月股份变动月报表,股本结构保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1139797475","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1139797475?lang=zh_cn&edition=full","pubTime":"2026-10-02 11:36","pubTimestamp":1790912161,"startTime":"0","endTime":"0","summary":"兆科眼科-B于2026年10月2日公布截至2026年9月30日止当月的证券变动月报。截至9月末,公司的已发行股本为548839012股,较上月底无变化。公告透露,5月至7月期间,兆科眼科-B曾购回合计1719500股普通股,这部分股份尚未注销,暂无进一步发行或注销安排。公司股本激励计划方面,期末预留的股份期权数量与上月持平,未见新增授出或行使情形。公告由公司董事李小羿代表签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06622"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183139280","title":"兆科眼科-B 2026年中期营收1,882.80万元,经调整净亏损1.16亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1183139280","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1183139280?lang=zh_cn&edition=full","pubTime":"2026-09-30 16:53","pubTimestamp":1790758396,"startTime":"0","endTime":"0","summary":"截至2026年6月30日止六个月,兆科眼科-B实现营收1,882.80万元,同比上年同期的1,580.30万元增长约19.17%。报告期内,公司经调整净亏损为1.16亿元,相比上年同期的1.15亿元扩大0.72%。毛利约为974.80万元,对应毛利率约51.76%,较上年同期的53.60%有所下降。成本方面,研发支出约1.06亿元,同比减少6.45%,销售及分销开支约2,482.50万元,同比增加6%,一般及行政费用约3,321.00万元,同比上升8.67%。公司经营活动所用现金流约8,876.50万元,相比上年同期的14,898.40万元,流出额收窄约40.37%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"兆科眼科-B 2026年中期营收1,882.80万元,经调整净亏损1.16亿元","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06622"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669246722","title":"董事总经理李烨妮增持李氏大药厂(00950.HK)20.6万股 每股作价1.15港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2669246722","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669246722?lang=zh_cn&edition=full","pubTime":"2026-09-24 19:24","pubTimestamp":1790249060,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["00950","BK1574","BK1191","BK1583","06622","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188227323","title":"创新药概念走高,云顶新耀、药明巨诺-B涨逾5%,金斯瑞生物科技涨逾4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1188227323","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1188227323?lang=zh_cn&edition=full","pubTime":"2026-09-23 11:01","pubTimestamp":1790132509,"startTime":"0","endTime":"0","summary":"9月23日,创新药概念走高,云顶新耀、药明巨诺-B涨逾5%,金斯瑞生物科技涨逾4%,康方生物、诺诚健华涨逾3%,基石药业涨逾2%,百济神州、药明生物、君实生物涨逾1%,信达生物跟涨。9月12-15日2026年世界肺癌大会召开,多项中国创新药临床数据集中亮相,康方生物依沃西单药OS数据、B7H3 ADC等成为焦点;与此同时,2026年国家医保目录谈判收官,商保创新药目录同步推进,支付端改革预期升温,\"出海商业化+支付改善\"的产业逻辑持续强化。","market":"hk","thumbnail":"https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06622","01801","00241","03759","02359","09688","03347","02268","06606","06618","02137","06978","06996","09966","09995","01672","02269","09606"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1145652378","title":"兆科眼科-B:YUVEZZI™中国II期临床达主要终点,拟推进III期试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1145652378","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1145652378?lang=zh_cn&edition=full","pubTime":"2026-09-04 18:46","pubTimestamp":1788518772,"startTime":"0","endTime":"0","summary":"2026年9月4日,兆科眼科-B公告称,其创新药卡巴胆碱酒石酸溴莫尼定滴眼液在中国开展的II期临床研究已达到预先设定的主要研究终点,显示出良好耐受性及安全性。结果显示,YUVEZZI在疗效和安全性方面均达到预期。根据香港联交所证券上市规则第18A.05条,兆科眼科-B提示,尚无法保证最终成功开发或商业化YUVEZZI。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06622"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664641336","title":"兆科眼科-B(06622.HK):卡巴胆硷酒石酸溴莫尼定滴眼液(YUVEZZI™)于中国老花眼患者的第II期研究中达到主要研究终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2664641336","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664641336?lang=zh_cn&edition=full","pubTime":"2026-09-04 18:41","pubTimestamp":1788518460,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1587","BK1574","BK1583","BK1191","06622"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159127199","title":"兆科眼科-B8月股份变动月报:已发行股份增至548,839,012股","url":"https://stock-news.laohu8.com/highlight/detail?id=1159127199","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1159127199?lang=zh_cn&edition=full","pubTime":"2026-09-02 15:56","pubTimestamp":1788335807,"startTime":"0","endTime":"0","summary":"兆科眼科有限公司于2026年9月2日披露截至2026年8月31日的股份变动月报表。根据公告,公司法定/注册股本与上月保持一致,均为1,600,000,000,000股普通股,每股面值0.00000025美元,法定/注册股本总额持平于400,000美元。报告期初公司已发行普通股共548,749,012股,期间因行使购股权新增发行90,000股,期末已发行普通股增至548,839,012股。在股份期权方面,报告期内按公司首发后购股权计划,因期权行使和失效进行相应调整。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06622"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0952},{"period":"1month","weight":-0.2292},{"period":"3month","weight":-0.2607},{"period":"6month","weight":-0.3791},{"period":"1year","weight":-0.3729},{"period":"ytd","weight":-0.3581}],"compareEarnings":[{"period":"1week","weight":-0.0452},{"period":"1month","weight":-0.0701},{"period":"3month","weight":-0.0749},{"period":"6month","weight":-0.111},{"period":"1year","weight":-0.1107},{"period":"ytd","weight":-0.099}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"兆科眼科有限公司是一家主要从事眼科药物及产品的开发、生产及营销的投资控股公司。该公司的主要产品包括用于治疗近视的NVK002(阿托品)、用于治疗干眼症的环孢素A眼凝胶以及用于治疗wAMD的TAB014(贝伐单抗)。该公司产品主要用于干眼症(DED)、近视、老花眼、湿性老年黄斑部病变(wAMD)和糖尿病黄斑水肿(DME)、青光眼及角膜上皮细胞功能障碍(CED)等影响眼前节及眼后节的眼科疾病的治疗。该公司在中国国内及海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.147188},{"month":2,"riseRate":0.2,"avgChangeRate":-0.134185},{"month":3,"riseRate":0.2,"avgChangeRate":-0.040318},{"month":4,"riseRate":0.2,"avgChangeRate":0.019445},{"month":5,"riseRate":0.333333,"avgChangeRate":0.015956},{"month":6,"riseRate":0.166667,"avgChangeRate":0.033584},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.047805},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.009984},{"month":9,"riseRate":0.5,"avgChangeRate":0.002914},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.109009},{"month":11,"riseRate":0.4,"avgChangeRate":0.029799},{"month":12,"riseRate":0.2,"avgChangeRate":-0.018114}],"exchange":"SEHK","name":"兆科眼科-B","nameEN":"ZHAOKE OPHTH-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"兆科眼科-B(06622)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供兆科眼科-B(06622)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"兆科眼科-B,06622,兆科眼科-B股票,兆科眼科-B股票老虎,兆科眼科-B股票老虎国际,兆科眼科-B行情,兆科眼科-B股票行情,兆科眼科-B股价,兆科眼科-B股市,兆科眼科-B股票价格,兆科眼科-B股票交易,兆科眼科-B股票购买,兆科眼科-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"兆科眼科-B(06622)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供兆科眼科-B(06622)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}